newsit

“Unlocking the Power of BMY: Positive CHMP Opinion for Opdivo-Yervoy Combo and Breyanzi Sparks Hope in the Medical Sector”

The CHMP Recommendations for Bristol Myers’ Opdivo and Yervoy Opdivo and Yervoy’s Approval in Hepatocellular Carcinoma Treatment Recently, the Committee for Medicinal Products for Human Use (CHMP) recommended the approval of Bristol Myers’ Opdivo plus Yervoy for the first-line treatment of hepatocellular carcinoma. This recommendation marks a significant advancement in the treatment options available for…

Read More

“Get Ready to Engage: Join Us at the Small Cap Growth Virtual Investor Conference on February 6th!”

Invitation to Join Virtual Investor Conference! Welcome Investors, Advisors, and Analysts! Let’s Dive into the World of Online Investing Hey there fellow investors, advisors, and analysts! Have you ever thought about attending a virtual investor conference from the comfort of your own home? Well, now is your chance! BEN is extending a warm invitation to…

Read More

“Uncovering the Numbers: GSI Technology Reports Q3 Loss, But Shows Year-Over-Year Improvement with Lower Costs”

GSIT Posts Q3 Loss Amid Nokia Sales Decline Company Focuses on AI and Defense Contracts for Growth Analysis of the Situation GSIT, a leading provider of innovative technologies, recently announced a loss in the third quarter due to a decline in Nokia sales and lower SigmaQuad shipments. Despite these challenges, the company remains optimistic about…

Read More